Electrophoretic separations
Scientists used quantitative analysis to trial anti-cancer agent
Aug 01 2011
In a study published by BMC Cancer, Chinese scientists investigated whether 5-allyl-7-gen-difluoromethoxychrysin (AFMC) could inhibit proliferation in various cancer cell lines and promote tumour necrosis.
In a method involving flow cytometry, propidium iodide fluorescence staining and agarose gel electrophoresis, the scientists found that subtoxic concentrations of AFMC make human non-small cell lung cancer (NSCLC) A549 cells more sensitive to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis.
Additionally, the study found that treating A549 cells with AFMC considerably provoked the expression of death receptor 5 (DR5), while also increasing the proliferation of Sub-G1 cells.
However, AFMC-mediated induction of DR5 expression was not observed in human embryo lung WI-38 cells, and AFMC did not makeWI-38 cells more sensitive to TRAIL-induced apoptosis.
The team suggested that AFMC "synergistically enhances TRAIL-mediated apoptosis in NSCLC cells" by increasing the amounts of DR5.
Events
Feb 03 2025 Dubai, UAE
Feb 05 2025 Guangzhou, China
Mar 01 2025 Boston, MA, USA
Mar 04 2025 Berlin, Germany
Mar 18 2025 Beijing, China